Showing results (531-540 of 686) with videos related to
Sort By:
Pageof 69
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2013
Diagnosis of covert hepatic encephalopathy without specialized testsEiman Nabi, Leroy R Thacker, James B Wade, et al.Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 28, 2017
Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosisJasmohan S Bajaj, Andrew Fagan, Masoumeh Sikaroodi, et al.Journal of Hepatology|August 26, 2018
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair Younossi, Maria Stepanova, Arun J Sanyal, et al.Journal of Hepatology|June 10, 2024
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosisEric J Lawitz, Mandy Fraessdorf, Guy W Neff, et al.Journal of Clinical Gastroenterology|December 27, 2018
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic SteatohepatitisBubu A Banini, Sophie C Cazanave, Katherine P Yates, et al.The Lancet. Diabetes & Endocrinology|May 6, 2014
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trialNorbert Stefan, Markus Ramsauer, Paul Jordan, et al.Contemporary Clinical Trials|March 3, 2021
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosisManal F Abdelmalek, Edgar D Charles, Arun J Sanyal, et al.The New England Journal of Medicine|October 20, 2021
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver DiseaseArun J Sanyal, Mark L Van Natta, Jeanne Clark, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 19, 2020
Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse modelAline de Conti, Volodymyr Tryndyak, Rose A Willett, et al.Pageof 69